Skip Navigation
ChemIDplus Lite•Browse•Advanced

Substance Name: Propofol [USAN:USP:INN:BAN]
RN: 2078-54-8
UNII: YI7VU623SF
InChIKey: OLBCVFGFOZPWHH-UHFFFAOYSA-N

Note

  • An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.

Molecular Formula

  • C12-H18-O

Molecular Weight

  • 178.273
 

Classification Codes

  • Anesthetic (Intravenous)
  • Anesthetics
  • Anesthetics, General
  • Anesthetics, Intravenous
  • Antiviral (COVID-19)
  • Central Nervous System Agents
  • Central Nervous System Depressants
  • Drug / Therapeutic Agent
  • Human Data
  • Hypnotics and Sedatives
  • Reproductive Effect
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Propofol
  • Propofol [USAN:USP:INN:BAN]

MeSH Heading

  • Propofol

Synonyms

  • 2,6-Bis(1-methylethyl)phenol
  • 2,6-Diisopropylphenol
  • 4-06-00-03435 (Beilstein Handbook Reference)
  • AI3-26295
  • Ampofol
  • Aquafo
  • BRN 1866484
  • CCRIS 9000
  • Diisopropylphenol
  • Diprifusor
  • Diprivan
  • Diprivan 10
  • Diprivan Injectable emulsion
  • Diprofol
  • Disoprivan
  • EINECS 218-206-6
  • Fresofol
  • HSDB 7123
  • ICI 35,868
  • ICI 35868
  • Ivofol
  • NSC 5105
  • Pofol
  • Propofol
  • Propofol-lipuro
  • Propofolum
  • Propofolum [Latin]
  • Propovan
  • Propoven
  • Rapinovet
  • Recofol
  • UNII-YI7VU623SF

Systematic Names

  • Disoprofol
  • Phenol, 2,6-bis(1-methylethyl)-
  • Phenol, 2,6-diisopropyl-

Registry Numbers

CAS Registry Number

  • 2078-54-8

FDA UNII

  • YI7VU623SF

Other Registry Numbers

  • 28449-97-0
  • 50356-15-5

System Generated Number

  • 0002078548

Structure Descriptors

InChI

InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3

InChIKey

OLBCVFGFOZPWHH-UHFFFAOYSA-N

Smiles

CC(C)c1cccc(C(C)C)c1O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 30mg/kg (30mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 38, Pg. 1117, 1996.
man LDLo intravenous 386mg/kg/14D- (386mg/kg) LUNGS, THORAX, OR RESPIRATION: PLEURAL THICKENING Critical Care Medicine. Vol. 23, Pg. 1928, 1995.
man TDLo unreported 2857ug/kg/1D- (2.857mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

BEHAVIORAL: REGIDITY

BEHAVIORAL: IRRITABILITY		 Anaesthesia. Vol. 43, Pg. 170, 1988.
mouse LD50 intraperitoneal 170mg/kg (170mg/kg)   Journal of Medicinal and Pharmaceutical Chemistry. Vol. 2, Pg. 201, 1960.
mouse LD50 intravenous 50mg/kg (50mg/kg) BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: ANALGESIA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)		 Journal of Medicinal Chemistry. Vol. 23, Pg. 1350, 1980.
mouse LD50 oral 1100mg/kg (1100mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
rabbit LDLo intravenous 20mg/kg (20mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: GENERAL ANESTHETIC

BEHAVIORAL: SLEEP		 Journal of Medicinal Chemistry. Vol. 23, Pg. 1350, 1980.
rat LD50 intravenous 42mg/kg (42mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 21, Pg. 11, 1993.
rat LD50 oral 500mg/kg (500mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.

Physical Properties

Physical Property Value Units Temp (deg C) Source
Melting Point 18 deg C   EXP
Boiling Point 256 deg C   EXP
pKa Dissociation Constant 11.1 (none) 20 EXP
log P (octanol-water) 3.79 (none)   EXP
Water Solubility 124 mg/L 25 EST
Vapor Pressure 3.05E-03 mm Hg 25 EST
Henry's Law Constant 2.12E-06 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 5.30E-11 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.